Supporting Information AdditionalSupportingInformationmaybefoundintheonline versionofthisarticle: Figure S1. Study design of the international, randomized, double-blind, parallel-group, multicentre, phase III study lasting208weeks(4years). Figure S2.CONSORTflowdiagram. Figure S3. Change in fasting plasma glucose over 208weeks (4years). Figure S4. Four-year change in urine glucose to creatinine ratio. FigureS5.Estimatedglomerularfiltrationrateoverthecourse of208weeks(4years;safetyanalysisset). Table S1. Summaryofelevatedliverfunctiontests. Table S2. Summaryofadverseeventsofhepaticdisorderand elevatedlivertests.